Literature DB >> 18559494

Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.

Mohammad R Abedini1, Emilie J Muller, Jan Brun, Richard Bergeron, Douglas A Gray, Benjamin K Tsang.   

Abstract

Understanding the mechanism of cisplatin (CDDP) action may improve therapeutic strategy for ovarian cancer. Although p53 and FLICE-like inhibitory protein (FLIP) are determinants of CDDP sensitivity in ovarian cancer, the interaction between p53 and FLIP remains poorly understood. Here, using two chemosensitive ovarian cancer cell lines and various molecular and cellular approaches, we show that CDDP induces p53-dependent FLIP ubiquitination and degradation, and apoptosis in vitro. Moreover, we showed that Itch (an E3 ligase) forms a complex with FLIP and p53 upon CDDP treatment. These results suggest that p53 facilitates FLIP down-regulation by CDDP-induced FLIP ubiquitination and proteasomal degradation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559494     DOI: 10.1158/0008-5472.CAN-08-0673

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Regulation of autoimmune disease by the E3 ubiquitin ligase Itch.

Authors:  Emily K Moser; Paula M Oliver
Journal:  Cell Immunol       Date:  2019-04-05       Impact factor: 4.868

2.  Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastoma.

Authors:  Ping Huang; M R Sandhya Rani; Manmeet S Ahluwalia; Eunnyung Bae; Richard A Prayson; Robert J Weil; Amy S Nowacki; Hirad Hedayat; Andrew E Sloan; Justin D Lathia; Jeremy N Rich; Russell Tipps; Candece L Gladson
Journal:  Cancer Res       Date:  2012-03-06       Impact factor: 12.701

3.  Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission.

Authors:  Lee Farrand; Sanguine Byun; Ji Young Kim; Akechai Im-Aram; Jihoon Lee; Semi Lim; Ki Won Lee; Jeong-Yong Suh; Hyong Joo Lee; Benjamin K Tsang
Journal:  J Biol Chem       Date:  2013-07-05       Impact factor: 5.157

4.  Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.

Authors:  Rosario Yerbes; Abelardo López-Rivas
Journal:  Invest New Drugs       Date:  2010-11-25       Impact factor: 3.850

5.  Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.

Authors:  Wei-Wei Pan; Jian-Jie Zhou; Xiao-Man Liu; Ying Xu; Lian-Jun Guo; Chao Yu; Qing-Hua Shi; Heng-Yu Fan
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

6.  Cellular responses to Cisplatin-induced DNA damage.

Authors:  Alakananda Basu; Soumya Krishnamurthy
Journal:  J Nucleic Acids       Date:  2010-08-08

Review 7.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10

8.  Cell fate regulation by gelsolin in human gynecologic cancers.

Authors:  Mohammad R Abedini; Pei-Wen Wang; Yu-Fang Huang; Mingju Cao; Cheng-Yang Chou; Dar-Bin Shieh; Benjamin K Tsang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

Review 9.  Targeting apoptotic caspases in cancer.

Authors:  Ashley Boice; Lisa Bouchier-Hayes
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-02-19       Impact factor: 4.739

10.  Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein.

Authors:  Rachel P Wilkie-Grantham; Shu-Ichi Matsuzawa; John C Reed
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.